This week Papua New Guinea’s health minister announced that their polio outbreak is under control, and the Indian government shared efforts to target mobile and migratory populations to prevent re-emergence of the virus. Meanwhile the general secretary of Rotary International, John Hewko, explained how the polio eradication infrastructure could be used to reach other public health goals.
A vaccination campaign got underway in Sierra Leone to tackle a measles outbreak, while Indonesia announced its ambition to achieve 95% coverage in a Gavi-funded vaccination drive with the measles-rubella vaccine.
A study found that India’s Gavi-funded PCV vaccination will be worth the cost, and another illustrated the economic benefits of hepatitis B screening. Elsewhere in research, Spanish scientists shared their work developing an Ebola vaccine against all five known strains, and a new study explained how immune system discovery could help develop improved vaccines for infants and newborns.
Finally, four 2018 pacesetters were announced this week at Gavi’s INFUSE vaccine technology workshop in San Francisco. At the same time, Gavi announced a partnership with Shifo, a previous pacesetter, to ensure more children in The Gambia have a digital health record and access to immunisation.